EUVIMEDEUVIMED entdecken
Open Access

The World Health Organization classification of pancreaticobiliary cytopathology stratifies risk of malignancy and outcome for endoscopic ultrasound‐guided fine‐needle aspiration of the pancreas

Shu Kwun Lui, Imani Hargett, Zaynab Pharaa, Mariela Aviles, Stephany Botelho, Dominique L Feliciano, Veronica Kim, Keith Sigel, Misha Armstrong, Christina E Wilson, Pari Shah, Kevin Soares und 1 weitere

Cancer Cytopathology · 2023-12 · 131 (12) · 762-771

DOI: 10.1002/cncy.22754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, online erschienen am 21.08.2023. Verfasst von Shu Kwun Lui und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cysts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, National Institutes of Health/National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The World Health Organization (WHO) has recently published a classification for reporting pancreaticobiliary cytopathology with differences compared to the Papanicolaou Society of Cytopathology (PSC) classification.

Methods

Retrospective data were collected from pancreatic endoscopic ultrasound‐guided fine‐needle aspirations from 2014 to 2017 at a pancreatic cancer center. Absolute risk of malignancy (AROM), relative risk (to benign), performance characteristics, and overall survival were calculated for the entire cohort with comparison of cysts and solid lesions.

Results

In total, 2562 cases were included: 16% cyst ( n = 411) and 84% solid ( n = 2151). The histologic confirmation rate was 43% ( n = 1101) and the median follow‐up (for benign) was 56 months. For WHO I–VII, overall AROM (%) was 23, 22, 62, 13, 65, 97, and 100; cyst AROM was 7, 0, 19, 13, 38, 78, and 100; and solid AROM was 50, 29, 70, 15, 100, 99, and 100. For PSC I–VI, overall AROM (%) was 23, 29, 64, 0 (IVa), 60 (IVb), 97, and 100; cyst AROM was 7, 0, 19, 0, 21, 78, and 100; and solid AROM was 50, 35, 73, 0, 92, 99, and 100. The difference in relative risk for a cyst (vs. solid) overall was 0.38 for WHO and 0.26 for PSC. WHO and PSC categories showed stratification for the probability of overall survival.

Conclusions

Cystic versus solid lesion type can dramatically affect AROM, particularly for nondiagnostic (I), benign (II), atypical (III), and WHO V categories. WHO IV conveys a similarly low AROM for cystic and solid types. Both classifications stratify the probability of overall survival, including the newly introduced categories WHO IV and WHO V.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCystsHumansRetrospective StudiesPancreasEndoscopic Ultrasound-Guided Fine Needle AspirationCytodiagnosis

Stichwörter der Autor:innen

World Health Organizationcytopathologyendoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)pancreaspancreaticobiliaryrisk of malignancy

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Carlie Sigel

Förderung

  • NCI NIH HHS
  • Marie-Josée and Henry R. Kravis Center for Molecular Oncology
  • National Institutes of Health/National Cancer Institute

Zitieren

APA

Lui, S. K., Hargett, I., Pharaa, Z., Aviles, M., Botelho, S., Feliciano, D. L., Kim, V., Sigel, K., Armstrong, M., Wilson, C. E., Shah, P., Soares, K., & Sigel, C. (2023). The World Health Organization classification of pancreaticobiliary cytopathology stratifies risk of malignancy and outcome for endoscopic ultrasound‐guided fine‐needle aspiration of the pancreas. Cancer Cytopathology, 131(12), 762-771. https://doi.org/10.1002/cncy.22754

Vancouver

Lui SK, Hargett I, Pharaa Z, Aviles M, Botelho S, Feliciano DL, et al. The World Health Organization classification of pancreaticobiliary cytopathology stratifies risk of malignancy and outcome for endoscopic ultrasound‐guided fine‐needle aspiration of the pancreas. Cancer Cytopathology. 2023;131(12):762-771. doi:10.1002/cncy.22754

BibTeX
@article{Lui2023,
  author = {Lui, Shu Kwun and Hargett, Imani and Pharaa, Zaynab and Aviles, Mariela and Botelho, Stephany and Feliciano, Dominique L and Kim, Veronica and Sigel, Keith and Armstrong, Misha and Wilson, Christina E and Shah, Pari and Soares, Kevin and Sigel, Carlie},
  title = {The World Health Organization classification of pancreaticobiliary cytopathology stratifies risk of malignancy and outcome for endoscopic ultrasound‐guided fine‐needle aspiration of the pancreas},
  journal = {Cancer Cytopathology},
  year = {2023},
  volume = {131},
  number = {12},
  pages = {762--771},
  doi = {10.1002/cncy.22754}
}
Kostenlos starten →